Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score) - 26/08/11
Doi : 10.1016/j.amjcard.2003.11.036
Srinivas Addala, MD a, Cindy L Grines, MD a, Simon R Dixon, MBChB a, Gregg W Stone, MD b, Judith A Boura, MS a, Anthony B Ochoa, MD a, Gregory Pellizzon, MD a, William W O'Neill, MD a, Joel K Kahn, MD a, ⁎ 
a William Beaumont Hospital, Royal Oak, Michigan, USA
b Lenox Hill Heart and Vascular Institute, New York, New York, USA
*Dr. Kahn's address is: Division of Cardiology, William Beaumont Hospital, 3601 West 13 Mile Road, Royal Oak, Michigan 48073, USA
Abstract |
We performed a pooled analysis of the Primary Angioplasty in Myocardial Infarction (PAMI) trials to examine predictors of death after primary percutaneous coronary intervention. Using these data, we developed a risk score with a range of 0 to 15 points. The PAMI risk score was found to be a strong predictor of late mortality.
Il testo completo di questo articolo è disponibile in PDF.© 2004
Excerpta Medica Inc. Tutti i diritti riservati.
Vol 93 - N° 5
P. 629-632 - marzo 2004 Ritorno al numero
Articolo precedente
- Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease
- Pablo Avanzas, Ramón Arroyo-Espliguero, Juan Cosin-Sales, Juan Quiles, Emmanouil Zouridakis, Juan Carlos Kaski
- Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry)
- Pedro A Lemos, Chourmouzios A Arampatzis, Francesco Saia, Angela Hoye, Muzaffer Degertekin, Kengo Tanabe, Chi-Hang Lee, Paul Cummins, Pieter C Smits, Eugène McFadden, Georgios Sianos, Pim de Feyter, Willem J van Der Giessen, Ron T van Domburg, Patrick W Serruys
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?